Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetes
Resveratrol fails to improve blood sugar in type 2 diabetes
This umbrella review and meta-analysis of 10 meta-analyses evaluated resveratrol for managing type 2 diabetes. While a significant reduction…
Resveratrol supplements did not lower blood sugar or improve cholesterol in type 2 diabetes, except for a small drop in LDL cholesterol.
SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes
SGLT2 inhibitors associated with lower mortality in heart transplant patients
This meta-analysis examined the impact of SGLT2 inhibitor use on outcomes for heart transplant recipients with type 2 diabetes. The authors …
New analysis suggests SGLT2 inhibitors may lower death rates for heart transplant recipients with type 2 diabetes without increasing UTI ris…
Single-incision sleeve plus bypass shows short-term safety and metabolic improvement in 3 patients with obesity and T2DM
SILSG-JJB Procedure Shows Promise for Weight Loss and Diabetes
This case report and review describes 3 female patients with severe obesity and type 2 diabetes who underwent single-incision laparoscopic s…
A new surgical approach may help people with severe obesity and Type 2 Diabetes achieve weight loss and better blood sugar levels.
Transcriptomic analysis identifies 337 high-confidence genes associated with Type 2 Diabetes in human pancreatic islets
Meta-analysis reveals 337 genes linked to type 2 diabetes in islets
This meta-analysis of transcriptomic data from human pancreatic islets identified 337 high-confidence T2D-associated genes. The study also d…
A meta-analysis of human pancreatic islets identified 337 high-confidence genes tied to type 2 diabetes, and a 10-gene panel perfectly disti…
SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
SGLT2 inhibitors show promise for heart failure and diabetes
This narrative review examines the cardiovascular and metabolic effects of SGLT2 inhibitors, specifically empagliflozin and dapagliflozin. T…
New evidence shows how SGLT2 inhibitors may protect the heart and manage risks for patients with type 2 diabetes and heart failure.
Metformin is associated with higher lactate concentrations during exercise in adults with prediabetes and type 2 diabetes
Metformin May Raise Lactate During Exercise
This meta-analysis of 325 participants evaluated the impact of metformin on exercise metabolism and capacity. The analysis found that metfor…
A new analysis suggests metformin may increase lactate levels during exercise, which could affect workout intensity.
Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD
Semaglutide lowers kidney and heart risks in type 2 diabetes patients
This randomized controlled trial enrolled 3,533 participants with type 2 diabetes and chronic kidney disease. Once-weekly subcutaneous semag…
A large trial shows once-weekly semaglutide reduces kidney failure and death risks in people with type 2 diabetes and chronic kidney disease…
Preoperative comorbidities linked to reduced weight loss after metabolic and bariatric surgery in adults
Pre-existing health conditions may slightly reduce weight loss after surgery
A meta-analysis of twenty-three studies reveals that mental illness, diabetes, and sleep apnea are associated with slightly lower weight los…
Adults with mental illness or diabetes before surgery saw slightly less weight loss. Other conditions like high blood pressure did not affec…
GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia
GLP-1 drugs may slow cognitive decline in type 2 diabetes
A systematic review of systematic reviews and meta-analyses found that GLP-1 receptor agonists are associated with reduced overall cognitive…
A review of reviews suggests GLP-1 drugs like Ozempic may help protect memory and thinking in people with type 2 diabetes.
Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
Evolocumab cuts heart events in high-risk diabetes patients
This prespecified subgroup analysis of a phase 3 RCT evaluated evolocumab added to statin therapy in 3655 high-risk patients with type 2 dia…
Adding evolocumab to statins reduced heart attacks and strokes by about 30% in high-risk diabetes patients without known heart disease.
Insulin degludec/liraglutide ranks highest for HbA1c reduction with SUCRA value of 89.4%
Comparing Combination Diabetes Drugs for Blood Sugar Control
This network meta-analysis evaluated 12,815 patients with type 2 diabetes to compare fixed-ratio combination products and their individual c…
A review of 12,815 patients found that insulin degludec/liraglutide may be best for lowering blood sugar, but has more side effects than oth…
scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes
Review explores scFv biologics for Type 1 and Type 2 diabetes care
This narrative review explores the potential of single-chain variable fragment (scFv)-based biologics for treating type 1 and type 2 diabete…
This review looks at scFv-based biologics for diabetes. It discusses how these treatments might help with immune control and blood sugar bal…
Research across Diabetes
Related studies from across the Diabetes family.
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
Digital health tools show mixed results for managing chronic diseases
Digital tools show promise for heart failure monitoring but lack consistent evidence for improving medication adherence or general diabetes …
New data shows that while digital tools like apps can help heart failure patients monitor their health, they may not improve medication habi…
Pharmacist-led telepharmacy may improve medication adherence and reduce blood pressure in patients with NCDs
Pharmacist Led Telepharmacy May Improve Medication Adherence For Chronic Illness
This systematic review analyzed 21 trials involving 5440 participants to evaluate pharmacist-led telepharmacy for managing non-communicable …
Remote pharmacist services through phone or video may help patients with high blood pressure and diabetes stick to their daily medication pl…
Pancreatic cancer involves multilayered mechanisms from environment to immune escape
Review reveals complex causes of pancreatic cancer
This narrative review synthesizes the multilayered mechanisms of pancreatic cancer, including environmental exposure, genetic susceptibility…
Pancreatic cancer arises from a mix of genetics, lifestyle, and inflammation, review finds.
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
High prevalence of microvascular and macrovascular complications among adult Ugandans with diabetes
High rates of diabetes complications found in adult Ugandans
This meta-analysis examined the prevalence of various diabetic complications, including neuropathy and retinopathy, in a large cohort of adu…
More than half of Ugandan adults with diabetes suffer from nerve damage, highlighting a critical need for earlier screening and better care.
Immunometabolic dysregulation drives hyperalgesia and hypoesthesia in diabetic peripheral neuropathy
New research explores how inflammation drives nerve damage in diabetes
This narrative review explores the pathophysiology of diabetic peripheral neuropathy, focusing on how hyperglycemia, lipotoxicity, and intes…
Chronic high blood sugar causes more than just high glucose; it triggers a cycle of inflammation and immune stress that damages nerves.
Chronic hyperglycemia causes multi-level nerve damage across the peripheral, autonomic, and central nervous systems
Understanding how high blood sugar damages the entire nervous system in diabetes
This narrative review synthesizes how chronic hyperglycemia impacts the entire neuroaxis in patients with diabetes. It details metabolic and…
High blood sugar can damage nerves throughout the whole body. This affects your senses, movement, and internal organs.
Pancreatic tissue engineering faces vascularization hurdle in type 1 diabetes therapy
New tissue engineering methods aim to improve pancreatic transplants
This narrative review examines pancreatic tissue engineering for type 1 diabetes, highlighting insufficient vascularization as the dominant …
Current pancreas transplants are limited by a shortage of donors and the need for lifelong drugs. New engineering techniques may offer a dif…
CAR technology for autoimmune disorders, infectious diseases, fibrotic lesions, inflammatory bowel disease, and type 1 diabetes is reviewed
Chimeric antigen receptor technology may help treat autoimmune disorders and other conditions
This narrative review discusses the application of chimeric antigen receptor (CAR) technology across autoimmune disorders, infectious diseas…
A narrative review suggests chimeric antigen receptor technology could be useful for treating autoimmune disorders, infectious diseases, and…
HIV linked to lower odds of post-TB lung disease; undernutrition raises risk
Undernutrition and HIV may lower or raise lung damage risk after tuberculosis in low-income nations
This systematic review and meta-analysis of 41 studies in LMICs found that HIV was associated with reduced odds of spirometry-defined post-t…
New analysis of data from low-income countries shows mixed results on how HIV, diabetes, and poor nutrition affect lung health after tubercu…
Meta-analysis finds no link between early-life antibiotics and type 1 diabetes risk
Antibiotics in Pregnancy Don’t Raise Child’s Diabetes Risk, Study Finds
This meta-analysis of early-life antibiotic exposure found no significant association with type 1 diabetes incidence in the general populati…
This large review offers reassurance that standard antibiotic use during pregnancy and infancy is safe regarding type 1 diabetes risk, with …
Review of ADSC-Exos for diabetic foot ulcers lacks reported efficacy data or safety outcomes in this narrative synthesis
Stem cell exosomes may help heal diabetic foot ulcers
This narrative review addresses the use of adipose-derived stem cell exosomes for diabetic foot ulcers and diabetes. The authors note that k…
A review suggests that exosomes from stem cells could improve healing for diabetic foot ulcers, offering a new treatment option.
Questions about Type 2 Diabetes
What common genes link Polycystic Ovary Syndrome and type 2 diabetes according to recent studies?
Recent studies link PCOS and type 2 diabetes through shared genetic variants, notably the insulin gene VNTR and epigenetic changes in metabolism-related genes.
Full answer →What are the standard treatment options available for someone with Type 2 Diabetes?
Standard treatment for type 2 diabetes includes lifestyle changes (diet, exercise), metformin, other medications like GLP-1 agonists (e.g., semaglutide, tirzepatide), and sometimes insulin, along with monitoring blood sugar and managing cardiovascular risk.
Full answer →What are the best lifestyle changes to manage Type 2 Diabetes effectively?
A Mediterranean diet, regular physical activity, weight loss, and digital health tools can effectively manage type 2 diabetes, with medication support as needed.
Full answer →All Type 2 Diabetes Articles
- Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetes
- SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes
- Single-incision sleeve plus bypass shows short-term safety and metabolic improvement in 3 patients with obesity and T2DM
- Transcriptomic analysis identifies 337 high-confidence genes associated with Type 2 Diabetes in human pancreatic islets
- SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
- Metformin is associated with higher lactate concentrations during exercise in adults with prediabetes and type 2 diabetes
- Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD
- Preoperative comorbidities linked to reduced weight loss after metabolic and bariatric surgery in adults
- GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia
- Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
- Long-term voglibose use likely caused leukopenia in a 71-year-old man with type 2 diabetes
- scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes
- Insulin degludec/liraglutide ranks highest for HbA1c reduction with SUCRA value of 89.4%
- Metabolic subtypes identify Japanese adults with prediabetes at highest or lowest T2D risk
- Eating later in the biological day is associated with impaired glucose regulation and reduced insulin sensitivity
- 37 loci linked to gestational diabetes, 7 novel, in large multi-ancestry meta-analysis
- AI-driven cardiovascular risk prediction in type 2 diabetes shows promise but bias and lack of diversity limit clinical use
- GLP-1 receptor agonists show no increased ocular disorder risk in type 2 diabetes meta-analysis
- GLP-1RAs show lower risk of serious liver events compared with DPP-4 inhibitors in adults with type 2 diabetes
- Real-time CGM improved HbA1c versus SMBG in adults with type 2 diabetes on basal insulin and modern therapies
- Sitagliptin and liraglutide superior for CGM targets in type 2 diabetes
- Thiazolidinediones show lower hepatocellular carcinoma risk than DPP-4 inhibitors, GLP-1RAs, insulin, and sulfonylureas in this network meta-analysis
- SGLT2 inhibitor use associated with increased diabetic ketoacidosis risk, especially with elevated HbA1c
- Paternal metformin use during spermatogenesis shows no increased risk for major congenital malformations in over 11 000 children across five countries
- Resistance training reduces hemoglobin A1c by 0.62% and systolic blood pressure by 3.91 mmHg in type 2 diabetes
- Multicomponent behavioral interventions show sustained HbA1c reduction in type 2 diabetes
- Greater weight loss and supervised exercise reduce diabetes risk in adults with prediabetes
- Lifestyle programs show no significant diabetes incidence reduction in 14 studies of at-risk individuals
- Trans fatty acids from dairy foods show no increased cardiometabolic risk in systematic review and meta-analysis
- SGLT2 and dual SGLT1/2 inhibitors reduce cardiovascular death or heart failure hospitalization risk in type 2 diabetes patients
- Triple oral therapy with metformin, SGLT-2, and DPP-4 inhibitors lowers HbA1c better than dual regimens in adults with type 2 diabetes
- Natural polysaccharides enhance insulin sensitivity and protect pancreatic beta-cells in type 2 diabetes
- Probiotics, synbiotics, and berberine modestly lower fasting glucose and HbA1c in type 2 diabetes
- Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controls
- Systematic review and meta-analysis of tirzepatide effects on HbA1c and weight in adults with type 2 diabetes
- Network meta-analysis compares exercise types for glycemic control in type 2 diabetes
- Genetic analysis links GLP-1 agonism to pancreatitis risk and sarcopenia in large cohorts
- Meta-analysis identifies rare gene-trait associations across 1.2 million individuals in global biobanks
- Systematic review and meta-analysis of lifestyle interventions for Type 2 Diabetes in West Africa
- Review of lifestyle factors linked to Type 2 Diabetes risk in Qatar
- Meta-analysis finds higher intrapancreatic fat in type 2 diabetes
- CGM may boost treatment satisfaction in type 2 diabetes, but other outcomes unclear
- Narrative review proposes FISI tools for metabolic syndrome and diabetes management across the life cycle
- Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
- Systematic review of curcumin with piperine for metabolic and cardiometabolic conditions
- Meta-analysis of Mendelian randomization suggests GLP-1 receptor agonism lowers vascular dementia risk
- Meta-analysis: Resistance training improves vascular function in type 2 diabetes
- Review of GLP-1RAs in Type 2 Diabetes and Atherosclerosis Mechanisms
- Meta-analysis of blood pressure levels and outcomes in type 2 diabetes participants
- Systematic review and meta-analysis on VR for Type 2 Diabetes management
- Pediatric Gut Microbiome Links to Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes
- Network meta-analysis compares bexagliflozin efficacy and safety with other SGLT2 inhibitors in type 2 diabetes
- Systematic review and meta-analysis of HIIT versus MICT for Type 2 Diabetes outcomes
- Meta-analysis of GWAS in Native Hawaiians and Polynesians identifies 25 trait loci for diabetes and obesity traits
- Systematic review of 88 observational studies on missing data reporting in T2DM-MCI research
- Meta-analysis finds Type 2 diabetes linked to poorer survival in solid tumor patients on immune checkpoint inhibitors
- Network meta-analysis compares glucose-lowering therapies for heart failure with reduced ejection fraction and type 2 diabetes
- Systematic Review and Meta-Analysis of Subcutaneous CGM in Elective Surgery
- Systematic review of saponins for type 2 diabetes and its complications
- Digital Health Interventions Show Mixed Results for Cardiovascular Risk Reduction in Type 2 Diabetes Patients Across Weight Categories
- Tirzepatide improves standard and intensive therapeutic target attainment versus semaglutide in adults with type 2 diabetes
- Personalized diabetes texting with peer support improved glycemic control and remission rates in type 2 diabetes patients
- Afternoon/Evening Exercise May Lower Blood Pressure More Than Morning Exercise: Meta-Analysis
- Systematic review and meta-analysis links Mediterranean diet to improved cardiometabolic markers
- Text messaging plus educational materials improves healthy eating in uncontrolled diabetes
- Systematic review and meta-analysis links Type 2 Diabetes to higher fracture risk across multiple anatomical sites
- Fasting plasma glucose shows higher diagnostic accuracy than HbA1c for undiagnosed diabetes in adults
- Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
- A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes
- Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
- Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
- Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months
- Reversion of Prediabetes to Normoglycemia Linked to 68% Lower Diabetes Risk
- Ecnoglutide Reduces HbA1c and Body Weight in Type 2 Diabetes: Meta-Analysis
- Meta-analysis finds GLP-1RA plus SGLT2i reduces UACR in type 2 diabetes with kidney disease
- Systematic review and meta-analysis of hypoglycaemia risk prediction models in type 2 diabetes
- GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates
- Narrative review discusses pharmacological and lifestyle interventions for type 2 diabetes and psychological health
- Guideline narrative review discusses diabetes risks from immunosuppressive therapy in kidney transplant recipients
- Baseline anti-GIP antibody levels associate with future diabetes-range glycemia in health checkup cohort
- Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
- Review of miRNA associations with high-risk diabetes profiles in midlife women
- Baseline vitamin D levels linked to semaglutide glycemic and weight outcomes in type 2 diabetes
- GenMetS polygenic score association with cardiometabolic risk in Asian populations
- Semaglutide high dose for weight reduction in people with Type 2 Diabetes
- Individual-participant data meta-analysis shows blood-pressure lowering reduces cardiovascular risk in CKD and non-CKD populations
- Machine learning model improves early detection of occult diabetic kidney disease in hospitalized patients
- High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
- Observational study suggests multi-omic scores improve Type 2 Diabetes risk assessment in UK Biobank and MESA cohorts
- Meta-analysis suggests Hatha yoga may improve blood pressure and glucose in non-communicable disease patients
- Telemedicine applications in general practice show positive clinical outcomes for chronic diseases
- Metformin use in Type 2 Diabetes shows inconsistent clinical effects in review
- Combination valsartan and dapagliflozin improves blood pressure and glucose in Type 2 Diabetes and hypertension
- Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models
- Meta-analysis of dapagliflozin for renal outcomes in type 2 diabetes and CKD
- Semaglutide linked to lower neuropsychiatric event risk vs other diabetes drugs in observational study
- Observational review of layered data models improves DKD risk detection in type 2 diabetes cohorts
- Higher ZJU index associated with worse metabolic profiles in adults with type 2 diabetes and hyperuricemia
- Observational Study Evaluating Hospital-Based Chronic Disease Management Platform in Adults With Type 2 Diabetes
- Meta-analysis links genetic variants to gestational diabetes mellitus risk in British, Finnish, and Chinese populations
- Meta-analysis of sex differences in insulin therapy outcomes for adults with Type 1 and Type 2 diabetes
- Scoping review on AI fundus photography for Type 2 Diabetes highlights limited external validation and calibration
- Higher Geriatric Nutritional Risk Index linked to lower osteoporosis risk in diabetic women
- Salivary growth factors differ in type 2 diabetes after tooth extraction
- Systematic review suggests resveratrol may improve glycemic control and protect pancreatic beta-cell function in diabetes
- Retinal microvascular features associated with subclinical cardiovascular dysfunction in type 2 diabetes
- Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT
- Non-traditional lipid indices associate with coronary heart disease risk in MASLD and type 2 diabetes patients
- Narrative review compares tirzepatide and semaglutide for obesity and type 2 diabetes outcomes
- TyG-WC and TyG-WHtR indices associated with liver-related events in type 2 diabetes
- FluxPro-DKD fusion model integration shows higher AUC for early-stage DKD detection in type 2 diabetes
- Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study
- Untargeted LC-MS/MS profiling identifies metabolite networks associated with glycemic dysregulation in diabetes cohorts
- IGFBP2 as a context-dependent regulator of metabolic dysregulation in obesity and type 2 diabetes
- Retrospective cohort study assesses diagnostic accuracy for Wagner Grade ≥2 DFUs in hospitalized type 2 diabetes patients
- Laboratory study examines SLC30A8 R138X variant effects on human stem cell-derived islet-like clusters
- Review of new-user target trial emulation comparing semaglutide and SGLT2i in U.S. Veterans with type 2 diabetes
- Systematic review and meta-analysis of oxidative stress biomarkers in older adults with T2DM or Parkinson's disease
- Genetic analyses suggest causal links between type 2 diabetes markers and cerebral small vessel disease phenotypes
- Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions
- Meta-analysis of Gynostemma pentaphyllum for glycemic control in diabetes patients
- Observational biobank study compares phenomic and social determinants for disease risk prediction
- Retrospective cohort finds COVID-19 infection linked to proteinuria progression in type 2 diabetes
- Monitoring report on US GLP-1 RA prescribing trends shows increased oral semaglutide use
- Young-onset type 2 diabetes and menopause status linked to all-cause mortality in Chinese women
- SBSPON gene variant rs2291219 linked to higher T2DM risk in Northwest Indian population
- Three-parameter online nomogram predicts diabetic retinopathy risk in community-dwelling type 2 diabetes patients
- Inflammatory and metabolic indices associated with microvascular complications in hospitalized type 2 diabetes patients
- Tirzepatide shows greater lean body mass loss than semaglutide in first-episode GLP-1RA users with type 2 diabetes
- Cross-Sectional Analysis of Protective Foot Sensation and Complications in 387 Type 2 Diabetes Patients
- Bioinformatics study identifies shared immune genes and potential drugs for PCOS and T2DM
- Mazdutide monotherapy reduces HbA1c and promotes weight loss in Chinese adults with type 2 diabetes over 48 weeks
- Systematic review and meta-analysis of Mendelian randomization studies examining T2DM and cancer associations
- Multidisciplinary management in T2DM patients yielded a 29.24% remission rate in a single-arm observational study
- Bayesian network meta-analysis evaluates antidiabetic medications and dementia risk in 4,382,897 patients
- Preprint paired analysis suggests VSG may improve metabolic and renal markers in youth with T2D and obesity
- Mini-review links insulin to worse COVID-19 outcomes in type 2 diabetes patients
- GLP-1RA use shows sex-specific pancreatitis and hypotension risks in T2D second-line therapy study
- In older in-patients with type 2 diabetes and cognitive impairment, CGM showed superior glucose metrics compared to point-of-care tests
- GLP1R locus variants associated with higher BMI and Type 2 Diabetes risk in genetically inferred European ancestry participants
- MTHFR C677T polymorphism linked to elevated risk of schizophrenia and type 2 diabetes comorbidity in Han Chinese patients
- Feijoa powder supplementation did not improve weight or glucose but lowered systolic blood pressure in adults with prediabetes
- Single-dose fultagliptin benzoate pharmacokinetics and safety in patients with mild to moderate renal insufficiency versus healthy volunteers
- PIEZO1 variant rs563555492T associated with lower HbA1c and reduced prediabetes risk in South Asian cohorts
- Single aerobic exercise bout shows mixed effects on glucose and neuronal insulin signaling in obesity
- Circulating spexin levels are significantly lower in patients with type 2 diabetes mellitus compared to controls
- Orforglipron shows superior HbA1c reduction versus oral semaglutide in adults with type 2 diabetes on metformin
- HALP score and clinical parameters predict time to glycemic stability in hospitalized type 2 diabetes patients
- Meta-analysis identifies risk factors for diabetic kidney disease in Asian patients with type 2 diabetes
- Meta-analysis finds high prevalence of adverse outcomes in African women with hyperglycaemia in pregnancy
- Post-hoc analysis finds both continuous and intermittent calorie restriction reduce weight in type 2 diabetes
- Intraduodenal Lauric Acid and Tryptophan Reduce Postprandial Glucose in Small Diabetes Trial
- Dairy-inclusive diet with timed meals may improve circadian gene expression and glycaemia in type 2 diabetes
- Biological age acceleration transitions associated with higher type 2 diabetes and mortality risk in UK Biobank cohort
- Higher dietary phytochemical index associated with better sleep quality in adults with type 2 diabetes
- Systematic review shows PCOS in obese women links to high MASLD and 2–4 fold increased cardiovascular and diabetes risks
- Protocol compares Mediterranean and low-carb diets for diabetes remission in Lebanese adults
- Elevated peripheral HIF-1α levels associated with higher fasting glucose and HbA1c in patients with type 2 diabetes mellitus
- QingYun7 dietary intervention improves glycemic control in patients with type 2 diabetes
- Low-load blood-flow restriction training improves mitochondrial capacity and fat loss in type 2 diabetes compared to conventional resistance training
- Technology-based interventions showed greater weight loss in women with prior gestational diabetes compared to control groups
- Network meta-analysis of novel antidiabetic drugs in T2DM with CKD shows sotagliflozin, empagliflozin, and semaglutide rank highest for cardiovascular and renal outcomes
- Network meta-analysis finds acupuncture therapies may improve glycemic parameters in type 2 diabetes
- Oral semaglutide reduces composite heart failure outcomes in patients with type 2 diabetes and heart failure history
- FDA Approves Dapagliflozin Tablets (dapagliflozin) for Heart Failure Risk Reduction and Glycemic Control in Type 2 Diabetes
- FDA Approves Dapagliflozin Tablets (dapagliflozin) for Type 2 Diabetes and Heart Failure Risk Reduction
- FDA Approves Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets for Type 2 Diabetes and Related Risks
- Pressure-controlled volume-guaranteed ventilation improved diaphragmatic function and reduced weakness in diabetic patients undergoing laparoscopic colorectal surgery
- Anal fistula incidence higher in diabetic patients; current management strategies may be suboptimal
- FDA Approves Dapagliflozin Tablets (dapagliflozin) to Reduce Heart Failure Hospitalization Risk and Improve Glycemic Control in Adults with Type 2 Diabetes
- FDA Approves Dapagliflozin for Heart Failure Risk Reduction and Glycemic Control in Type 2 Diabetes
- FDA Approves Dapagliflozin for Reducing Heart Failure Hospitalization Risk and Improving Glycemic Control in Adults with Type 2 Diabetes
- FDA Approves Dapagliflozin Tablets (dapagliflozin) for Type 2 Diabetes and Heart Failure Risk Reduction
- FDA Approves Dapagliflozin Tablets (dapagliflozin) for Heart Failure Risk Reduction and Glycemic Control in Type 2 Diabetes
- FDA Approves Dapagliflozin Tablets (dapagliflozin) for Heart Failure Risk Reduction and Glycemic Control in Type 2 Diabetes
- FDA Approves Dapagliflozin Tablets (dapagliflozin) to Reduce Heart Failure Hospitalization Risk in Adults with Type 2 Diabetes
- Elevated plasma phenylalanine associated with obesity, type 2 diabetes, and cancer risk
- Ticagrelor Not Noninferior to Prasugrel in Diabetes Patients With Multivessel CAD After PCI
- Urinary podocin and nephrin show poor short-term prediction of DKD progression in type 2 diabetes
- Finerenone linked to improved KDIGO risk categories in T2D and CKD patients
- PPARα rs6008845 genotype modifies fenofibrate benefit for vascular events in type 2 diabetes
- Resistance and interval training plus berry extract did not alter muscle AGEs in older adults
- GLP-1 receptor agonists associated with lower respiratory sequelae risk in case report analysis
- Tadalafil reduces some plasma neurodegeneration biomarkers in type 2 diabetes patients
- BP variability and pulse pressure associated with cognitive decline in type 2 diabetes patients
- Posterior slab cast shows higher healing rate than total contact cast for diabetic foot ulcers in single-center RCT
- Oral quadruple therapy reduces HbA more than metformin uptitration in type 2 diabetes on triple therapy
- Subgroup analysis finds tirzepatide superior to dulaglutide for HbA1c and weight in type 2 diabetes
- GLP-1RAs reduce MACE risk in Asian and White adults with diabetes or overweight
- Hepatic insulin resistance linked to greater central obesity in Korean adults with type 2 diabetes
- Exercise therapy shows benefits for type 2 diabetes management, but adherence challenges persist
- New-onset diabetes in adults over 50 associated with higher pancreatic cancer risk within 3 years
- Gluteus maximus morphology shows sex-specific associations with type 2 diabetes risk in UK Biobank imaging
- Plant bioactive polysaccharides show metabolic benefits in umbrella review of systematic reviews
- AI-ready dataset created for type 2 diabetes research, lacking clinical validation
- Self-management and glycemic control linked to lower MCI risk in rural elderly with type 2 diabetes
- LCHF and HCLF diets both improve HRQoL in type 2 diabetes, with no significant between-group difference
- Polypharmacy and age predict MACE in rural Montana type 2 diabetes cohort
- Vildagliptin reduces specific TG species in T2D; GLP-1 blockade increases total TGs
- Youth diabetes incidence increased from 2002-2015, with higher rates of increase in minority populations